IMA Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
CCMLC
CCA
IMA Advisory Services's LGND Position: Q2 2019 in Review
IMA Advisory Services sold out of Ligand Pharmaceuticals (LGND) in Q2 2019, closing a stake of 10 shares — an estimated $1K sold.
IMA Advisory Services first reported a position in LGND in Q2 2018 and held it in 4 quarters. The position peaked at $2K in Q3 2018. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.
- IMA Advisory Services reported no remaining Ligand Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- IMA Advisory Services sold 10 Ligand Pharmaceuticals shares in Q2 2019, an estimated $1K.
- IMA Advisory Services first reported a position in Ligand Pharmaceuticals in Q2 2018 and held it in 4 quarters.
- IMA Advisory Services's Ligand Pharmaceuticals position peaked at $2K in Q3 2018.
- 305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.
Based on IMA Advisory Services's 13F filing for Q2 2019, filed 19 Jul 2019.